Incidence of High-Level Evernimicin Resistance in Enterococcus faecium among Food Animals and Humans
Open Access
- 1 September 2002
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (9) , 3088-3090
- https://doi.org/10.1128/aac.46.9.3088-3090.2002
Abstract
Six high-level evernimicin-resistant Enterococcus faecium isolates were identified among 304 avilamycin-resistant E . faecium isolates from animals and 404 stool samples from humans with diarrhea. All four animal isolates, and one of the human isolates, were able to transfer resistance to a susceptible E . faecium strain. The resulting transconjugants all tested positive for the presence of emtA , a gene encoding a methyltransferase previously linked with high-level evernimicin resistance. The four transconjugants derived from animal isolates all carried the same plasmid, while a differently sized plasmid was found in the isolate from humans. This study demonstrated a low incidence of high-level evernimicin resistance mediated by the emtA gene in different E . faecium isolates of animal and human origin.Keywords
This publication has 19 references indexed in Scilit:
- Nonhuman Reservoirs of EnterococciPublished by American Society for Microbiology ,2014
- Antibiotic Resistance: An Ecological ImbalancePublished by Wiley ,2007
- Veterinary use and antibiotic resistancePublished by Elsevier ,2001
- Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in DenmarkAntimicrobial Agents and Chemotherapy, 2001
- Quinupristin/Dalfopristin-Resistant Enterococci of thesatA(vatD) andsatG(vatE) Genotypes from Different Ecological Origins in GermanyMicrobial Drug Resistance, 2000
- Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compoundsDiagnostic Microbiology and Infectious Disease, 1999
- Antimicrobial activity of SCH27899 (Ziracin®), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/Etest method evaluations and quality control guidelinesDiagnostic Microbiology and Infectious Disease, 1999
- Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the FutureEmerging Infectious Diseases, 1998
- Medical Consequences of Antibiotic Use in AgricultureScience, 1998
- Comparative in-vitro activity of SCH 27899, a novel eveminomicin, and vancomycinJournal of Antimicrobial Chemotherapy, 1996